The Financial Cost of Healthcare Fraud 2026
Healthcare organisations face growing financial pressures, yet one of the largest avoidable costs often remains hidden: fraud.
Drawing on almost three decades of global research, The Financial Cost of Healthcare Fraud 2026 provides an evidence-based assessment of the scale and impact of fraud across healthcare systems worldwide.
Based on 89 independently validated loss measurement exercises covering more than £9.62 trillion of healthcare expenditure, the report moves beyond detected cases and estimates the true cost of fraud using statistically robust methodologies.
The research examines four key areas of healthcare fraud:
- supplies fraud
- fraud by staff and managers
- fraud by medical professionals, and
- fraud by patients.
It highlights an estimated average healthcare fraud loss rate of 5.52%, providing organisations with a valuable benchmark for understanding their own exposure and identifying opportunities for cost reduction.
As healthcare providers seek sustainable ways to improve efficiency and release resources for frontline care, understanding the scale of fraud has never been more important. The report demonstrates that fraud losses can be measured, managed and reduced, enabling organisations to make informed decisions about investment in counter-fraud activity and financial controls.
Download the full report to explore the latest global data, key findings and practical insights into the financial cost of healthcare fraud.
Contact us
